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Apart from regulating stem cell self-renewal, embryonic development and proliferation, Bmi-1 has been recently reported to
be critical in the maintenance of genome integrity. In searching for novel mechanisms underlying the anticlastogenic function
of Bmi-1, we observed, for the first time, that Bmi-1 positively regulates p21 expression. We extended the finding that Bmi-1
deficiency induced chromosome breaks in multiple cancer cell models. Interestingly, we further demonstrated that knockdown
of cyclin E or ectopic overexpression of p21 rescued Bmi-1 deficiency-induced chromosome breaks. We therefore conclude
that p21/cyclin E pathway is crucial in modulating the anticlastogenic function of Bmi-1. As it is well established that the
overexpression of cyclin E potently induces genome instability and p21 suppresses the function of cyclin E, the novel and
important implication from our findings is that Bmi-1 plays an important role in limiting genomic instability in cylin
E-overexpressing cancer cells by positive regulation of p21.
Introduction
Bmi-1, a polycomb gene family member, is known to play
key roles in stem cell self-renewal, embryonic development
and proliferation.1–5 The expression of Bmi-1, strong in
undifferentiated cells, declines during differentiation3 and
diminishes in cells undergoing senescence.5 In addition, the
overexpression of Bmi-1 is commonly detected in many types
of human cancer.3,6–10 Knockdown of Bmi-1 inhibited the
proliferation and development of various types of human
tumors.11–13 In combination with other genetic alterations,
Bmi-1 functions as a proto-oncogene, as exempliﬁed by the
pioneer ﬁnding that Bmi-1 collaborates with Myc in tumori-
genesis in mice.14 One of the major functions of Bmi-1 is to
suppress or prevent the overexpression of p16ink4a and p19arf,
thus enabling cells to overcome cellular senescence.1,5 Yet,
accumulating evidence has revealed other functions of Bmi-1.
In mouse models of leukemia and glioma lacking expression
of p16ink4a and p19arf, the expression of Bmi-1 is still
required for malignancy development,15,16 indicating the
ink4a/arf-independent function(s) of Bmi-1. In human mam-
mary epithelial cells, Bmi-1 has been reported to induce telo-
merase activity to contribute to cellular immortalization.17
Bmi-1 has been found to regulate mitochondrial function;
and Bmi-1 deﬁciency leads to increased intracellular accumu-
lation of reactive oxygen species.18,19 Moreover, several recent
studies have shown that Bmi-1 has anticlastogenic functions
through promoting repair of DNA damage. In particular,
Bmi-1 is rapidly recruited to DNA damage sites.20–22 Deple-
tion of Bmi-1 resulted in radio-sensitivity of mammalian
cells.20–22 In Bmi-1-knockout mouse cells, S- and G2-phase
recovery was impaired.22 Moreover, Bmi-1 is involved in
DNA homologous recombination repair in human cancer
cells.22 These ﬁndings on the role of Bmi-1 in DNA damage
response/repair suggest that Bmi-1 plays important roles in
maintaining genome integrity. Indeed, the deﬁciency of Bmi-
1 has been found to induce spontaneous chromatid breaks in
293T (an immortalized human embryonic kidney cell line)
and HCT116 (a human colon cancer cell line).22 In the pres-
ent study, we extended the above ﬁnding by demonstrating
that Bmi-1 deﬁciency enhanced spontaneous chromatid
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breaks in multiple additional human cancer cell lines. We
also found, for the ﬁrst time, that the knockdown of Bmi-1
decreased the expression of p21WAF1/WIP1, and the forced
overexpression of Bmi-1 increased p21 expression, indicating
a role of Bmi-1 in positive regulation of p21 in human
cancer cells. We further demonstrated that the ectopic over-
expression of p21 rescued Bmi-1-deﬁciency-induced chroma-
tid breaks, suggesting that the decreased p21 expression after
Bmi-1 knockdown played a critical role in causing chromatid
breaks. One of the well-established functions of p21 is to
inhibit the function of cyclin E.23,24 The decreased expression
of p21 after Bmi-1 knockdown would allow over-activation
of cyclin E, which is known to be a patent inducer of struc-
tural chromosome instability.23,25 Indeed, we found that Bmi-
1 deﬁciency-induced chromatid breaks in cancer cells were
dependent upon cyclin E overexpression. Based on these
ﬁndings, we conclude that p21/cyclin E pathway is crucial in
the manifestation of genomic instability induced by Bmi-1
knockdown in cancer cells. As both cyclin E and Bmi-1 are
frequently overexpressed in cancer cells, the novel and
important implication from our ﬁndings is that Bmi-1 plays
a particularly important role in limiting genomic instability
in cylin E-overexpressing cancer cells.
Material and Methods
Cell lines
A cervical cancer cell line (HeLa), an osteosarcoma cell line
(U2OS) and a nasopharyngeal carcinoma cell line (HONE1)
were used in our study. HeLa and U2OS cells were cultured
in Dulbecco’s Modiﬁcation of Eagle’s Medium (DMEM)
medium (Sigma-Aldrich, St. Louis, MO) supplemented with
10% fetal bovine serum (FBS). HONE1 cells were cultured in
RPMI-1640 medium (Sigma-Aldrich) supplemented with
10% FBS. All cells were maintained at 37C in 5% CO2 incu-
bators. An immortalized cervical epithelial cell line NC104-
E6E7 was cultured in 1:1 mixture of EpiLife (Cascade Biolog-
ics) and deﬁned keratinocyte serum-free medium (Life Tech-
nologies) with the provided supplements.
RNA interference and ectopic p21 expression
Small interfering RNAs (siRNA) against human Bmi-1, cylin
E or control siRNA (scramble RNA sequence) were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA). The siR-
NAs were resuspended in RNAse-free water provided by
Santa Cruz Biotechnology as recommended by the manufac-
turer. Ectopic p21 expression vector, pCEP-p21, and the
empty vector, pCEP, were obtained from Addgene (deposited
by Prof. B. Vogelstein’s Laboratory,26 the Johns Hopkins Uni-
versity School of Medicine, Baltimore, MD). Before transfec-
tion, culture medium was changed to serum-free DMEM or
RPMI-1640. Cells were transfected with siRNA, pCEP-p21,
pMSCV-Bmi-1 or empty vectors with Lipofectamine 2000
(Invitrogen, Carlsbad, CA) for 3 hr. Then the culture
medium was refreshed with serum-containing medium, and
the cells were incubated for 48 hr before harvest for analysis.
Ectopic Bmi-1 expression
Retroviral vector for ectopic Bmi-1 expression, pMSCV-Bmi-
1 (also encoding puromycin-resistant gene), was kindly pro-
vided by Prof. Mu-Sheng Zeng at the State Key Laboratory of
Oncology in Southern China, Sun Yat-sen University Cancer
Center.7 The empty vector pMSCV (encoding puromycin-
resistant gene) was obtained from Yingrun Biotechnologies,
Changsha, China. The infectious viruses were produced from
phoenix 293 cells. Two days after retroviral infection, the
cells were selected with 1 mg/ml puromycin for 4 days. The
ﬁrst-passage cells after dug-selection were analyzed.
Chromosome aberration analysis
Metaphase chromosome spreads were prepared as previously
described.27 Chromosome were stained with DAPI (40,6-dia-
midino-2-phenylindole). Images under a 1003 lens of Leica
ﬂuorescence microscope were captured by computer with
SPOT software (Leica), and then analyzed on computer
screen. Two hundred metaphases were analyzed for each
datum of chromosome aberration frequency. Chromosome
aberrations in HeLa cells were also analyzed using 24-color
spectral karyotyping (SKY) as previously reported.28 Aberra-
tions were identiﬁed according the criteria of the Interna-
tional System for Human Cytogenetic Nomenclature [1995,
Mitelman F (ed); Karger, Basel].
Western Blotting analysis
Western Blotting was used to analyze the levels of protein
expression. Brieﬂy, 15 mg of the protein from the whole-cell
extract was separated by using 10% SDS-PAGE. The resolved
proteins in the gel were transferred onto a polyvinylidene ﬂuo-
ride membrane (Amersham, GE Health, Sweden) at room tem-
perature for 1.5 hr. The membrane was washed with 13 TBST
and blocked with 2% bovine serum albumin (BSA) (for p21 and
What’s new?
The gene Bmi-1 is overexpressed in many cancers, and it has been implicated in preventing chromosomal breakage. In this
paper, the authors discovered just how Bmi-1 may effect this protection. They observed that increasing or decreasing Bmi-1
expression also increased or decreased p21 expression; furthermore, adding p21 to cells that lack Bmi-1 prevented the
expected chromosome breaks. It’s known that p21 inhibits cyclin E, which is frequently overexpressed in cancer cells and can
also induce chromatid breaks. Therefore, Bmi-1 and p21 appear to promote cancer cell survival by protecting them from chro-
mosomal breakage caused by cyclin E.
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phospho-CHK1 analysis) or 10% nonfat milk (for other protein
analysis) in 13 TBST for 1 hr. After washing, the membrane
was incubated with primary antibodies in 1% BSA (for p21 and
phospho-CHK1 analysis) or 5% nonfat milk (other protein anal-
ysis) in 13 TBST at 4C overnight. The primary antibodies:
Bmi-1 (F6; 1:600) was from Upstate, Millipore (Billerica, MA);
p21WAF/Cip1 (1:200), cyclin E (1:1000) and actin (1:1000) were
from Santa Cruz Biotechnology; p53 (1:1000), phospho-
p53(ser15) (1:500), CHK1 (1:500) and phospho-CHK1(ser345)
(1:500) were from Cell Signaling Technology (Danvers, MA).
After washing twice with 13 TBST for 20 min, the membrane
was incubated with appropriate secondary antibodies (1:3,000)
in 5% nonfat milk in 13 TBST for 1 hr at room temperature.
After washing, the membrane was incubated with ECL-Plus
chemiluminescence kit (Amersham) for 5 min. The signals were
visualized using Biomax X-ray ﬁlm (Kodak, Rochester, NY).
BrdU (5-bromo-2-deoxyuridine) staining
Cells grown on coverslips were incubated with BrdU (10
mM) (Life Technologies, Grand Island, NY) for 1 hr, ﬁxed
with 100% methanol for 30 min on ice, washed with phos-
phate buffered saline and permeabilized with 0.3% Triton
X-100 at room temperature for 20 min. After washing with
13 TBST, the cells were incubated in 2 M HCl at room tem-
perature for 20 min, neutralize with 0.1 M borate buffer for 5
min, washed with 13 TBST, and incubated in 3% BSA in
13 TBST for 30 min. After washing, the cells were incubated
with anti-BrdU (1:400) (Dako, Glostrup, Denmark) for 1 hr
at room temperature, washed with 13 TBST, incubated with
second antibody (1:2,000) Alexa Flour 488 (Life Technolo-
gies) in 13 TBST for 1 hr at room temperature, and washed
again. The cells were counterstained with DAPI containing
antifade. The coverslips were mounted onto slides. The per-
centages of BrdU-positive cells out of 500 cells were scored
under a Leica ﬂuorescence microscope.
Immunofluorescence staining
Cells grown on coverslips were ﬁxed with 4% paraformalde-
hyde for 10 min on ice, and permeabilized with 0.3% Triton
X-100 at room temperature for 20 min. After washing with 13
TBST, the cells were incubated in 3% BSA (resuspended in 13
TBST) for 30 min. After washing, the cells were incubated with
anti-g-H2AX (Upstate, Millipore) (1:500) in 1% BSA for 1 hr
at room temperature, washed, incubated with second antibody
(1:2,000) Alexa Flour 488 (Life Technologies) for 1 hr at room
temperature, and washed again. Then the cells were counter-
stained with antifade-containing DAPI. The coverslips were
mounted onto slides. Images were captured under a Leica ﬂuo-
rescence microscope by computer with SPOT software (Leica),
and analyzed on computer screen.
Statistical analysis
Student’s t-test was used to analyze differences between
experimental groups. A p value 0.05 was considered statisti-
cally signiﬁcant.
Results
Bmi-1 knockdown induced spontaneous chromatid breaks
in multiple cancer cell lines
As Bmi-1 is commonly overexpressed in cancer cells, we
reduced Bmi-1 expression by using siRNA against Bmi-1 to
investigate the role of Bmi-1 in chromosomal instability in
multiple cancer cell lines of different origins. We used HeLa
and U2OS (a cervical cancer and an osteosarcoma cell line,
respectively), which are widely used in chromosomal instabil-
ity study, and HONE1 (a commonly used nasopharyngeal
carcinoma cell line) as our cell models. The successful Bmi-1
knockdown was conﬁrmed by Western Blotting results
shown in Figure 1a. Of various forms of structural chromo-
some abnormalities analyzed using metaphase chromosome
staining, the frequencies of spontaneous chromatid breaks
were found signiﬁcantly increased in cells after Bmi-1 knock-
down (p< 0.05, Fig. 1b). Examples of Bmi-1 knockdown-
induced chromatid breaks were shown in Figure 1c. There
were no signiﬁcant changes in total chromosome number or
ploidy after Bmi-1 knockdown when compared to the cells
transfected with scramble RNA sequences (data not shown).
These results are in line with the previous report that Bmi-1
deﬁciency increased spontaneous chromatid breaks in 293T
and HCT116 cell lines22 and extend the ﬁnding to other car-
cinoma cell lines.
The exhibition of chromatid breaks after Bmi-1 knockdown
involved the function of cyclin E overexpression in cancer
cells
It is known that spontaneous structural chromosome instabil-
ity can be caused by endogenous replicative stress induced by
hyperactivation of S-phase promoting oncogenes presumably
through compromising prereplication complex assembly and
licensing of origins of replication.29,30 Cyclin E is one of the
typical oncogenes promoting S-phase progression to induce
replicative stress and structural chromosome instabil-
ity.23,25,29,30 We therefore ﬁrst examined whether the chroma-
tid breaks in Bmi-1 knockdown-cells were related to
alteration in expression levels of cyclin E in cancer cells. Our
Western Blotting analysis showed that Bmi-1 knockdown
modestly increased the expression levels of cyclin E in U2OS
and HONE1 cells but not signiﬁcantly the HeLa cells. Of
note, compared to the other two cell lines, HeLa cell line had
a remarkably higher basal level of cyclin E expression, which
may render the change in cyclin E expression less sensitive to
the knockdown of Bmi-1 (Fig. 1a). As cyclin E is frequently
overexpressed in cancer cells,31 we then knocked down cyclin
E expression by siRNA in Bmi-1 knockdown cells to examine
the potential involvement of cyclin E in chromatid breaks
induced by the knockdown of Bmi-1 expression. The signiﬁ-
cant knockdown of cyclin E expression was conﬁrmed by
Western Blotting analysis (Fig. 2a). The cyclin E knockdown
did not impair the effectiveness of Bmi-1 knockdown, as evi-
denced by the similar low level of or barely detectable
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Figure 2. Bmi-1 knockdown-induced chromatid breaks were rescued by knockdown of cyclin E. (a) Western Blotting analysis confirmed the
effective knockdown of cylin E and (b) Frequencies of chromatid breaks 48 hr after transfection with siRNA against Bmi-1 together with
siRNA against cyclin E or scramble RNA. Two hundred metaphases were analyzed. Error bars indicate SD.
Figure 1. Western Blotting and chromosome aberration analysis. (a) Western Blotting analysis for protein expression; (b) Frequencies of
chromatid breaks 48 hr after transfection with siRNA against Bmi-1 and scramble RNA (siControl). Two hundred metaphases were analyzed.
Error bars indicate standard deviation (SD) and (c) Examples of chromatid breaks (indicated by arrows) in HeLa cells.
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expression of Bmi-1 compared to the Bmi-1 expression levels
in the cells without cyclin E knockdown (Fig. 2a). Strikingly,
chromosome aberration analysis showed that cyclin E knock-
down signiﬁcantly reduced the chromatid breaks induced by
Bmi-1 knockdown (p< 0.05). This result demonstrated that
Bmi-1 knockdown-induced chromatid breaks in the cancer
cell lines involved the function of cyclin E overexpression.
Bmi-1 knockdown-induced chromatid breaks were
dependent upon decreased p21 expression
The dependence of Bmi-1 knockdown-induced chromatid
breaks on the original cyclin E overexpression indicates that
other factor(s) regulating the active function of cyclin E may
be involved. As p21 and p53 are known to suppress cyclin E
function, we then examined whether Bmi-1 knockdown
altered the expression levels of p21 and p53. Although the
expression levels of p53 and phosph-p53(ser15) were not
consistently changed across the three cell lines after Bmi-1
knockdown (Fig. 1a), we consistently detected the decreased
expression of p21 in the cells with Bmi-1 knockdown com-
pared to the cells transfected with scramble siRNA sequences.
This ﬁnding was repeated by multiple authors of this manu-
script in independent experiments. Therefore, the exhibition
of chromatid breaks induced by Bmi-1 knockdown might
involve the decreased expression of p21.
To address whether the reduced expression of p21 truly
contributed to the induction of chromatid breaks after Bmi-1
knockdown, we performed rescue experiments by cotransfect-
ing p21-expressing plasmids together with siRNA against
Bmi-1 into the three cancer cell lines. Western Blotting
results conﬁrmed the successful overexpression of p21 (Fig.
3a). The ectopic p21 overexpression did not alter the effective
knockdown of Bmi-1, as demonstrated by the similar low lev-
els of Bmi-1 expression compared to those without p21 over-
expression (Fig. 3a). Interestingly, chromosome aberration
analysis revealed that the ectopic overexpression of p21
decreased the frequencies of chromatid breaks to the back-
ground levels (Fig. 3b) when compared to the frequencies in
cells only transfected with siControl RNA (scramble siRNA)
(Fig. 1b). These results demonstrated that the reduced p21
expression played a critical role in the induction of chroma-
tid breaks after Bmi-1 knockdown in cancer cells.
Ectopic overexpression of Bmi-1 increased p21 expression
The result that Bmi-1 knockdown decreased p21 expression
indicates that Bmi-1 may positively regulate p21 expression.
We therefore directly tested whether overexpression of Bmi-1
could increase p21 expression. Among the three cancer cell
lines we examined, HONE1 cell line has the lowest level of
Bmi-1 expression as can be seen from the expression levels
in siControl RNA-treated cells (Fig. 1a). We therefore further
examined the effects of overexpression of Bmi-1 in HONE1
cells using Bmi-1-expressing vectors. The infected cells from
the ﬁrst passage after the drug selection were harvested for
Figure 3. Bmi-1 knockdown-induced chromatid breaks were rescued by ectopic p21 overexpression. (a) Western Blotting analysis confirmed
the effective p21 overexpression and (b) Frequencies of chromatid breaks 48 hr after transfection with siRNA against Bmi-1 together with
pCEP-p21 or empty vector. Two hundred metaphases were analyzed. Error bars indicate SD.
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Western Blotting analysis. Our result showed that p21
expression was clearly increased in the cells with the overex-
pression of Bmi-1 when compared to the cells infected with
empty retroviral vectors (Fig. 4). We extended the experiment
to an immortalized cervical epithelial cell line, NC104-E6E7,
which was immortalized by expression of HPV16-E6E7.32
This cell line was chosen because of its low basal level of
Bmi-1 expression among multiple immortalized and cancer
cell lines we screened. Again, Bmi-1 overexpression clearly
increased p21 expression in NC104-E6E7 cells. Our results
from Bmi-1 knockdown or ectopic overexpression experi-
ments support that Bmi-1 positively regulates p21 expression.
In addition, the ectopic overexpression of Bmi-1 in HONE1
cells also decreased the frequency of spontaneous chromatid
breaks by half (5 chromatid break/500 metaphases in Bmi-1
overexpressing HONE-1 cells) compared to 12 chromatid
break/500 metaphases in control cells transfected with empty
vectors. The immortalized NC104-E6E7 cells had a low fre-
quency of spontaneous chromatid breaks (2 chromatid break/
500 metaphases), and no further decrease in the frequency of
spontaneous chromatid breaks could be observed after Bmi-1
overexpression.
Bmi-1 knockdown increased proportions of cells with DNA
synthesis
One of the major functions of cyclin E is to promote S-phase
entry, but the over-activation of cyclin E can cause hyper-
replication-related replicative stress thus slows S-phase pro-
gression or completion, leading to increase of cell proportion
in S-phase.23 Considering the well-established role of p21 in
inhibiting the function of cyclin E,23,24 we speculated that the
reduced expression of p21 after Bmi-1 knockdown may lead
to functional activation of cyclin E, resulting in increased
proportion of cells undergoing DNA synthesis. To test this
hypothesis, we used bromodeoxyuridine (BrdU) labeling
(which accurately reﬂects DNA synthesis in cells) to measure
active S-phase proportion under normal growth condition
after Bmi-1 knockdown. Two days after transfection with
siRNA against Bmi-1 or scramble siRNA sequences, the cells
were incubated with medium containing BrdU for 1 hr and
harvested for nuclear staining of BrdU. Examples of BrdU
staining were shown in Figure 5a. As predicted, the percen-
tages of cells with nuclear BrdU staining in the three cancer
cell lines after Bmi-1 knockdown increased signiﬁcantly when
compared to control cells transfected with scramble siRNA
sequences (Fig. 5b).
Bmi-1 knockdown enhanced replicative stress in cancer
cells
In mammalian cells, the presence of endogenous replicative
stress (without challenge with exogenous DNA damage sour-
ces) can be detected by S-phase-restricted pan-nuclear stain-
ing of phosphorylated form of H2AX (g-H2AX),33,34 which
contrasts with the punctuate pattern (foci formation) of g-
H2AX induced by exogenous sources that cause DNA dou-
bling strand breaks or endogenous DNA damage in non-S-
phase cells.35 The pan-nuclear staining of g-H2AX has been
used to detect cyclin E overexpression-induced replicative
stress in a previous study.34 We therefore used pan-nuclear
g-H2AX staining (exempliﬁed in Fig. 5c) as one of the
markers to indicate the degree of replicative stress in our
study. Bmi-1 knockdown in the three cancer cell lines signiﬁ-
cantly increased the percentages of cells with pan-nuclear g-
H2AX staining, indicative of replicative stress, when com-
pared to scramble siRNA transfection, (Fig. 5d). Notably, the
percentages of Bmi1-depleted cells with pan-nuclear g-H2AX
staining decreased signiﬁcantly after ectopic overexpression
of p21 (Fig. 5d).
CHK1 phosphorylation represents a classical and sensitive
response to replicative stress.36,37 Our Western Blotting anal-
ysis detected increased expression levels of phosphorylated
CHK1 in Bmi-1 knockdown cells compared to those in the
cells transfected with scramble siRNA (Fig. 1a). This was in
line with the notion that Bmi-1 knockdown increased replica-
tive stress.
As fragile sites are hot-spots of breakage induced by repli-
cative stress, we tested whether Bmi-1 knockdown preferen-
tially induced chromatid breaks at fragile sites in cancer cells.
Metaphases from HeLa cells after Bmi-1 knockdown were
analyzed using 24-color SKY and DAPI staining to identify
the breakpoint distribution on speciﬁc chromosome arms.
HeLa cells were chosen because of their relatively simple
chromosomal structural abnormalities which facilitated reli-
able identiﬁcation of chromosome bands on most of their
chromosome arms. Examples of SKY and DAPI images of
HeLa cells with chromatid breaks are shown in Figures 6a
and 6b. The list of all chromatid breakpoints in whole
Figure 4. Overexpression of Bmi-1 increased p21 expression ana-
lyzed using Western Blotting. Actin showed equal protein loading.
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genome of 200 metaphases is shown in Figure 6c. About
70% of breakpoints occurred at or near conventional fragile
sites that were previously identiﬁed.38 Although we did not
accurately map the ﬁne chromatid breakpoints, our data indi-
cate that there may be an association between chromatid
breakpoints and fragile sites.
Discussion
In elucidation of mechanisms underlying the Bmi-1 deﬁ-
ciency-induced chromosome instability, we found, for the
ﬁrst time, that Bmi-1-knockdown decreased the expression of
p21, and the ectopic overexpression of p21 rescued Bmi-1
knockdown-induced chromatid breaks in three out of three
cancer cell lines examined. These results demonstrated that
the decreased p21 expression is crucial for the manifestation
of chromatid breaks induced by Bmi-1 knockdown. Although
the detailed mechanisms regarding how the decreased p21
expression induced by Bmi-1 knockdown leads to structural
chromosome instability remains to be elucidated, our results
suggest that the functions of cyclin E may be involved. It has
been well-established that p21 suppresses the functions of
cyclin E.23,24 If unsuppressed, the activation of cyclin E can
potently induce structural chromosome instability by causing
replicative stress.23 The reduced p21 expression after Bmi-1
knockdown would lead to functional activation of cyclin E in
cells. Although we found only modest increase in the protein
expression levels of cyclin E after Bmi-1 knockdown in two
out of three cancer cell lines, we demonstrated, for the ﬁrst
time, that knockdown of cyclin E abolished the Bmi-1 knock-
down-induced chromatid breaks in cancer cells, implicating
the involvement of cyclin E in mediating the Bmi-1 knock-
down-induced chromatid breaks. One simple interpretation
of the results from the chromatid break rescue experiments
was that the ectopic p21 overexpression or cyclin E knock-
down in Bmi-1-knockdown cells could lead to G1- or S-
phase arrest, thus reducing replicative stress and decreasing
Figure 5. Bmi-1 knockdown increased the proportions of cells with DNA synthesis and replicative stress. (a) Examples of BrdU-staining to
indicate the cells with DNA synthesis; (b) Frequencies of BrdU-positive cells after transfection with siRNA against Bmi-1 or scramble RNA;
500 cells were analyzed and error bars indicate SD; (c) Example of pan-nuclear staining of g-H2AX (indicated by arrows) and (d) Frequen-
cies of pan-nuclear g-H2AX-positive cells after transfection with scramble siRNA, siRNA against Bmi-1, the combination of siRNA against
Bmi-1 and empty vectors, or the combination of siRNA against Bmi-1 and p21 overexpression vectors. Five hundred cells were analyzed
and error bars indicate SD. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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the formation of chromatid breaks in mitotic cells. In agree-
ment with the notion that Bmi-1 knockdown led to replica-
tive stress, we showed that the chromatid breaks after Bmi-1
knockdown might be associated with conventional fragile
sites. Bmi-1 knockdown also increased the percentages of
cells with pan-nuclear g-H2AX staining (speciﬁc marker of
replicative stress33,34), and elevated the expression levels of
phosphorylated CHK1, (classical and sensitive response to
replicative stress). Although CHK1 may suppress extensive
exhibition of replicative stress-induced chromosome instabil-
ity,39 it is evident that the response of CHK1 was not sufﬁ-
cient to completely suppress the formation of chromatid
breaks after Bmi-1 knockdown in cancer cells. Noteworthily,
we showed that the ectopic overexpression of p21 suppressed
the Bmi-1 knockdown-induced replicative stress (Fig. 5d),
which may explain the reduction in the frequencies of chro-
matid breaks in mitotic cells after ectopic p21 overexpression.
Our experiments further showed that Bmi-1 overexpression
increased p21 expression. Combined with the results of
decreased p21 expression after Bmi-1 knockdown, our results
revealed that Bmi-1 positively regulates p21 expression in
human cancer cells. This has been repeatedly conﬁrmed by
multiple experiments in the present study. Yet this ﬁnding is
contrary to our initial expectation based on the data from
mouse neural stem cells in which it was shown that Bmi-1 neg-
atively regulates p21 expression.40 We have not unraveled the
molecular mechanism of p21 regulation by Bmi-1 in our study.
It has been reported that Bmi-1 binds to p21 promoter to regu-
late p21 transcription.41 However, it is known that Bmi-1 can
differently regulate the expression levels of its target genes
depending on cell contexts. For example, after Bmi-1 knock-
down, E4F1 gene expression (one of the downstream target
genes of Bmi-1) was downregulated in E11 but on the contrary
upregulated in E16 neural progenitor cells.40 Other undeﬁned
factors may be involved in p21 regulation by Bmi-1 in human
cancer cell lines. The role of p53 in the response of p21 to
Bmi-1 knockdown is also unclear in the present study. The p53
is one of the well-known upstream regulators of p21. In our
study, we did not ﬁnd consistent changes in expression levels
of either total p53 or phosph-p53(ser15) (the activated form of
p53) after Bmi-1 knockdown in the cell lines with different sta-
tus of p53. HONE1 cells carry a heterozygous point mutation
at codon 280 in exon 8 of p53 gene42; U2OS and HeLa cells
carry wild-type p53 gene.43 However, HeLa cells are infected by
HPV18. Presumably, the p53 function in HeLa cells is inacti-
vated by the expression of HPV18-E6. Although p53 expression
levels did not show consistent change after Bmi-1 knockdown,
we could not absolutely exclude the involvement of p53 in the
regulation of p21 after Bmi-1 knockdown. The involvement of
p53 in p21 regulation by Bmi-1 warrants further investigation.
Figure 6. Bmi-1 knockdown induced chromatid breaks preferentially at fragile sites. (a) and (b) Two partial metaphases of HeLa cells with
chromatid breaks at fragile sites after Bmi-1 knockdown. Arrows indicate breakpoints. (c) The list of all chromatid breakpoints in 200 meta-
phases of HeLa cells after Bmi-1 knockdown. The breakpoints at or near conventional fragile sites were underlined. [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
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A previous study has shown that Bmi-1 depletion in mice
also exhibit a high frequency of spontaneous chromatid
breaks in primitive hematopoietic cells.22 In addition, the cul-
tures initiated from Bmi-12/2 hematopoietic stem cells exhib-
ited a signiﬁcant increase of cycling cells including increased
S- and G2-phase cells when compared to Bmi-11/1 hemato-
poietic stem cells. But eventually, higher frequencies of Bmi-
12/2 hematopoietic stem cells were succumbed to apoptosis
than Bmi-11/1 hematopoietic stem cells.22 Therefore,
genomic instability induced by Bmi-1 knockout was not
favorable to cell survival. In agreement with this, several
studies have shown that Bmi-1 knockdown suppressed the
proliferation of various types of human tumors.11–13
Although genomic instability is a hallmark of cancer and is
believed to play critical roles in cancer development, yet high
levels of genomic instability can affect cancer cell viability, which
is exploited by many chemotherapeutic reagents that induce
severe genomic instability. Therefore, restriction of genomic
instability at tolerable levels is beneﬁcial for continued prolifera-
tion and progression of cancer cells. As cyclin E is commonly
overexpressed in cancer cells,31 the important implication from
our study is that Bmi-1 may exert its protective function of
genome integrity in cyclin E-overexpressing cells at least in part
through upregulation of p21, hence, limiting genomic instability
at tolerable levels. In the light of the previous ﬁndings that Bmi-
1 promotes the response/repair after DNA damage,20–22 the
p21/cyclin E pathway is most unlikely the sole pathway that
modulates the anticlastogenic function of Bmi-1. Yet our ﬁnd-
ings in this study add a new dimension to the functions of Bmi-
1 in limiting spontaneous genomic instability in cancer cells.
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